SULINDAC
Generic: SULINDAC
Actavis PharmaManufacturer
ORALRoute
SULINDACActive Substance
1988-03-03Original Approval
SULINDAC is FDA application ANDA071891, sponsored by WATSON LABS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Top Reported Reactions
1
DRUG INEFFECTIVE
214 reports
2
PAIN
186 reports
3
FATIGUE
155 reports
4
ARTHRALGIA
144 reports
5
NAUSEA
129 reports
6
PAIN IN EXTREMITY
114 reports
7
ASTHENIA
107 reports
8
DIARRHOEA
107 reports
9
HEADACHE
104 reports
10
BACK PAIN
97 reports